# Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

> **NCT00548301** · PHASE3 · COMPLETED · sponsor: **Sirion Therapeutics, Inc.**

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT00548301
- **Lead sponsor:** Sirion Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548301, "Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00548301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*